Why Gilead Sciences' Successful COVID-19 Results Fell Flat | Jul 11 #stocks $GILD $REGN
- The measured benefit wasn't strong enough to be considered statistically significant at the interim update,  https://t.co/WY5v3Tv7ne https://t.co/mZ7X6yVljp